[Go to site: main page, start]
Asymmetric Learning - Pharmaceutical Innovation

Asymmetric Learning - Pharmaceutical Innovation

Home
Notes
Archive
About
GLP-1s for Obesity Were Hiding in Plain Sight: How Better “What If” Thinking Could Help Pharma Spot Opportunities Sooner
Bringing the GLP-1 curve forward by 3–7 years could have produced something in the order of hundreds of billions to low single‑trillion dollars of…
 • Mike Rea
Asymmetric Learning: What This Blog Has Been Trying To Say (All Along)
If you’ve been here for a while, or you’re new and drop into this blog’s archive, you’d be forgiven for thinking it’s a mess: GLP-1s and CAR-T, spies…
 • Mike Rea
The Data That Shows Asymmetric Learning Is Winning: Why Biotechs Now Bear the Clinical Trial Load
In 2020 I wrote about asymmetric learning as the quiet edge behind some of the biggest successes in biopharma.
 • Mike Rea
Standout Launches 2024–2025: Asymmetric learning beats first-mover advantage
At its core, this blog is about launching better - the asymmetry in how you launch, what you launch, and therefore the difference in the revenues on…
 • Mike Rea
Acquiring Biotech Innovation: Why Big Pharma’s External Bets Often Outperform Internal Discovery (At Lower Risk-Adjusted Cost)
In the world of pharmaceutical innovation, one truth stands out: the path from molecule to market seems littered with ‘failure’.
 • Mike Rea
You Keep Using That Word
Innovation Theatre in Pharma (15 Years Later)
 • Mike Rea
Asymmetric Learning from the Shadows: What WWII Spies Teach Pharma About Covers, Tells, and Truth-Seeking
I’ve always been fascinated by stories from war of undercover agents who integrated perfectly into enemy territory.
 • Mike Rea
Asymmetric Learning - Pharmaceutical Innovation
Asymmetric Learning - Pharmaceutical Innovation
Innovations in Pharmaceutical Innovation A blog/ part-work from Mike Rea, CEO of IDEA Pharma, exploring pharmaceutical innovation in general, and more specifically the approach to using the learning process for competitive advantage
Recommendations
View all 7
BowTiedBiotech
BowTiedBiotech
BowTiedBiotech
mumble | delegate | ponder
mumble | delegate | ponder
Bonny P McClain
Adjacent Possible
Adjacent Possible
Steven Johnson
User's avatar
Pharmaceutical Positioning
Mike Rea
One Useful Thing
One Useful Thing
Ethan Mollick

Asymmetric Learning - Pharmaceutical Innovation

AboutArchiveRecommendationsSitemap
© 2026 Mike Rea, IDEA Pharma · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture
    This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts